Archive


Category: ~$1.1B

  • Medtronic to Acquire Intersect ENT for ~$1.1B

    Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by H1’22 The acquisition will expand Medtronic’s product portfolio which is used in the ENT procedure. Additionally, the acquisition will add a bioabsorbable drug release platform […]